Phase II study of salvage therapy with high-dose tamoxifen and oral etoposide for recurrent malignant glioma

Author： Chang Susan M   Lamborn Kathleen R   Malec Mary   Rabbitt Jane   Page Margaretta   Prados Michael D  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.1, Iss.1, 2004-09, pp. : 53-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 330-332

Karger

Access to resources Recommend Favorite

Early Tandem High-Dose Ifosfamide, Carboplatin, Etoposide Therapy with Stem Cell Rescue for Small-Cell Lung Cancer: Brief Report on the Results of a Phase-I/II Trial

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 248-253

Karger

Access to resources Recommend Favorite

Phase II Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 88-95

Karger

Access to resources Recommend Favorite

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 824-834

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study

By  

Urologia Internationalis, Vol. 90, Iss. 1, 2012-11 ,pp. : 56-61

Karger

Access to resources Recommend Favorite